LHC Machine Protection

For nominal beam parameters at 7 TeV/c each of the two LHC proton beams has a stored energy of 362 MJ threatening to damage accelerator equipment in case of uncontrolled beam loss. The energy stored in the magnet system at 7 TeV/c will exceed 10 GJ. In order to avoid damage of accelerator equipment, complex machine protection systems are required. Magnet protection and powering interlock systems must be operational already before commissioning the magnet powering system. Beam operation, throughout the operational cycle from injection to colliding beams, requires fully operational protection systems, including beam interlock systems, beam dumping system, beam instrumentation (mainly beam loss monitors) as well as collimators and beam absorbers. Details of LHC machine protection have been presented on several occasions and the systems involved in protection are well documented [1]. This paper gives an overview of LHC machine protection, discusses the progress with the implementation and presents first results from the commissioning of some systems

Toward Collaborative Print Retention

Background: :In order to serve the many member libraries who were faced with the loss of space and the subsequent need to downsize and discard print collections in a very short time, the NN/LM SE/A formed a task force on print retention in the spring of 2010. This group carried on online discussions and met twice between the Spring of 2010 and The Spring of 2011. The task force recommended, among other things, that a committee be formed to identify the potential for a collaborative print retention project in the region, develop educational resources on the topic of print retention, and recommend future directions. Methods: The ad-hoc committee met, brainstormed ideas, and developed a survey for resource and primary access libraries. The committee received responses from 128 libraries. Conclusions: An interesting and encouraging discovery was that almost one and a half times as many libraries expressed an interest in participating in a print retention project as were feeling pressure to give back space to their parent institution. This led the committee to conclude that space pressures and the resulting loss of print resources are a continuing concern for health sciences libraries. Even those who are not now facing pressures are interested in collaboration. Moreover, only a small number of the libraries were currently participating in print retention projects. The committee recommended that the NN/LM SE/A, in collaboration with the National Library of Medicine, continue work to develop a collaborative print retention project and to educate members on the resources available.https://nsuworks.nova.edu/hpd_lib_presentations/1004/thumbnail.jp

The LHC Injection Tests

A series of LHC injection tests was performed in August and September 2008. The first saw beam injected into sector 23; the second into sectors 78 and 23; the third into sectors 78-67 and sectors 23-34-45. The fourth, into sectors 23-34-45, was performed the evening before the extended injection test on the 10th September which saw both beams brought around the full circumference of the LHC. The tests enabled the testing and debugging of a number of critical control and hardware systems; testing and validation of instrumentation with beam for the first time; deployment, and validation of a number of measurement procedures. Beam based measurements revealed a number of machine configuration issues that were rapidly resolved. The tests were undoubtedly an essential precursor to the successful start of LHC beam commissioning. This paper provides an outline of preparation for the tests, the machine configuration and summarizes the measurements made and individual system performance

Human Iron−Sulfur Cluster Assembly, Cellular Iron Homeostasis, and Disease†

ABSTRACT: Iron-sulfur (Fe-S) proteins contain prosthetic groups consisting of two or more iron atoms bridged by sulfur ligands, which facilitate multiple functions, including redox activity, enzymatic function, and maintenance of structural integrity. More than 20 proteins are involved in the biosynthesis of iron-sulfur clusters in eukaryotes. Defective Fe-S cluster synthesis not only affects activities of many iron-sulfur enzymes, such as aconitase and succinate dehydrogenase, but also alters the regulation of cellular iron homeostasis, causing both mitochondrial iron overload and cytosolic iron deficiency. In this work, we review human Fe-S cluster biogenesis and human diseases that are caused by defective Fe-S cluster biogenesis. Fe-S cluster biogenesis takes place essentially in every tissue of humans, and products of human disease genes, including frataxin, GLRX5, ISCU, and ABCB7, have important roles in the process. However, the human diseases, Friedreich ataxia, glutaredoxin 5-deficient sideroblastic anemia, ISCU myopathy, and ABCB7 sideroblastic anemia/ataxia syndrome, affect specific tissues, while sparing others. Here we discuss the phenotypes caused by mutations in these different disease genes, and we compare the underlying pathophysiology and discuss the possible explanations for tissue-specific pathology in these diseases caused by defective Fe-S cluster biogenesis. HUMAN CELLULAR IRON HOMEOSTASI

Study of an energy upgrade of the CERN PS Booster

CERN’s LHC injector chain will have to deliver beams with ultimate brilliance as the LHC is heading for increased luminosity in the coming years. In order to overcome bottlenecks in the injector chain, an increase of the beam transfer energy from the CERN Proton Synchrotron Booster (PSB) to the Proton Synchrotron (PS) has been investigated as a possible upgrade scenario. This paper gives an overview of the technical solutions and summarizes the conclusions of the feasibility study

Status of the Upgrade of the CERN PS Booster

The CERN PS Booster (PSB) is presently undergoing an ambitious consolidation and upgrade program within the frame of the LHC Injectors Upgrade (LIU) project. This program comprises a new injection scheme for H- ions from CERN’s new Linac4, the replacement of the main RF systems and an energy upgrade of the PSB rings from 1.4 to 2 GeV which includes the replacement of the main magnet power supply as well as the upgrade of the extraction equipment. This paper describes the status and plans of this work program

Consensus Paper: Pathological Mechanisms Underlying Neurodegeneration in Spinocerebellar Ataxias.

Intensive scientific research devoted in the recent years to understand the molecular mechanisms or neurodegeneration in spinocerebellar ataxias (SCAs) are identifying new pathways and targets providing new insights and a better understanding of the molecular pathogenesis in these diseases. In this consensus manuscript, the authors discuss their current views on the identified molecular processes causing or modulating the neurodegenerative phenotype in spinocerebellar ataxias with the common opinion of translating the new knowledge acquired into candidate targets for therapy. The following topics are discussed: transcription dysregulation, protein aggregation, autophagy, ion channels, the role of mitochondria, RNA toxicity, modulators of neurodegeneration and current therapeutic approaches. Overall point of consensus includes the common vision of neurodegeneration in SCAs as a multifactorial, progressive and reversible process, at least in early stages. Specific points of consensus include the role of the dysregulation of protein folding, transcription, bioenergetics, calcium handling and eventual cell death with apoptotic features of neurons during SCA disease progression. Unresolved questions include how the dysregulation of these pathways triggers the onset of symptoms and mediates disease progression since this understanding may allow effective treatments of SCAs within the window of reversibility to prevent early neuronal damage. Common opinions also include the need for clinical detection of early neuronal dysfunction, for more basic research to decipher the early neurodegenerative process in SCAs in order to give rise to new concepts for treatment strategies and for the translation of the results to preclinical studies and, thereafter, in clinical practice.JOURNAL ARTICLESCOPUS: cp.jinfo:eu-repo/semantics/publishe